- Home
- CYN vs ICU Comparison
CYN vs ICU Comparison
Compare CYN & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYN | ICU |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United States | United States |
| Employees | 62 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 10.6M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CYN | ICU |
|---|---|---|
| Price | $0.27 | $0.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 183.4K | 179.7K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $368,138.00 | ★ $1,234,000.00 |
| Revenue This Year | $424.72 | $62.07 |
| Revenue Next Year | $596.26 | $50.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 814.07 |
| 52 Week Low | $0.25 | $0.22 |
| 52 Week High | $4.10 | $5.38 |
Technical Indicators
Market Signals| Indicator | CYN | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 25.78 | 19.50 |
| Support Level | N/A | N/A |
| Resistance Level | $0.44 | $2.85 |
| Average True Range (ATR) | 0.03 | 0.20 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 13.02 | 0.04 |
Price Performance
Historical ComparisonAbout CYN Cyngn Inc.
Cyngn Inc is an industrial autonomous vehicle technology company, focused on addressing industrial uses for autonomous vehicles. It develops full-stack autonomous driving software, DriveMod, which is integrated into vehicles manufactured by original equipment manufacturers during the assembly process. The company designs its software to be compatible with a range of sensors and hardware components and integrates it with its own systems to enable autonomous vehicle functionality.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.